GGrantIndex
← Search

NOVEL THERAPEUTIC AGENTS (CELECOXIB) AGAINST BREAST CANCER:PHASE II TRIAL DESIGN

$3,396M01FY2005RRNIH

Children'S Research Institute, Washington DC

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →